• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Tetragenetics

edit

Tetragenetics, Inc. is an early-stage biotechnology company meeting the needs of customers who seek a cost-effective alternative platform technology for the production of genetically engineered proteins. Their technology is particularly well suited to the production of eucaryotic membrane and secretory proteins that are difficult to express in conventional systems. Such proteins include vaccine antigens, monoclonal antibodies, and a variety of therapeutic proteins for the treatment and prevention of human and animal disease.

Recent Milestones

edit

• 
  Tetragenetics — named Marco Cacciuttolo as president and CEO (6/13/11)
  Posted 6/14/11 at 5:40am via masshightech.com
• 
  Tetragenetics received $490k in Venture Round funding. (11/24/09)
  Posted 12/7/09 at 2:26pm via sec.gov
• 
  Tetragenetics added Marco Cacciuttolo as President and CEO.
  Posted 6/13/11 at 5:38pm
• 
  Tetragenetics added Ben Machielse as Board of Directors.
  Posted 6/13/11 at 5:38pm
• 
  Tetragenetics added Robert Gailus as Board of Directors.
  Posted 6/13/11 at 5:38pm

Videos

Screenshots

edit

Sources

1. SEC D (sec.gov) [edit]
Tetragenetics names new CEO, board members, headquarters (masshightech.com) [edit]